键凯科技开启PEG填塑新纪元：旗下丝玫瑰携手北京首玺丽格新品上市

Core Viewpoint - The launch event of SILKROSE, a brand under JianKai Technology, marks a significant milestone in showcasing China's innovative strength in medical beauty materials, particularly with the introduction of PEG cross-linked hyaluronic acid gel [1][7]. Group 1: Event Overview - The event was co-hosted by SILKROSE and Beijing Shouxi Lige, featuring industry experts and leaders discussing the future of the medical beauty industry under the "Healthy China" strategy [3]. - The event emphasized the importance of independent innovation in medical materials technology to promote sustainable development in the medical beauty sector [3]. Group 2: Product Innovation - SILKROSE is positioned as a systematic solution to address pain points in the traditional filling market, aiming to reshape the industry landscape [4]. - The PEG material technology utilized in SILKROSE represents a significant innovation, transitioning the medical beauty industry from "scale growth" to "value innovation" [4]. Group 3: Clinical Application Standards - The new clinical application standards for SILKROSE were presented, highlighting the need for filling materials to provide both dynamic integration and static support [5]. - SILKROSE offers a comprehensive solution for clinical practitioners, including injection techniques and dosage planning, transforming material science innovation into standardized clinical practices [5]. Group 4: Strategic Partnerships - A strategic partnership was established between SILKROSE and Beijing Shouxi Lige, with the latter being awarded the title of "Chief Medical Guidance Expert," enhancing collaboration in the industry [5]. - This partnership exemplifies the synergy between production, academia, research, and application, aiming to set new industry benchmarks [5]. Group 5: Technological Breakthroughs - SILKROSE, as the first domestically developed injectable PEG cross-linked hyaluronic acid gel, underwent nine years of research and received NMPA Class III medical device certification [7]. - The PEG cross-linking technology ensures no residuals remain post-degradation, offering high biocompatibility and a natural filling effect [7]. Group 6: Industry Vision - The event transcended product promotion, fostering discussions on the future of the medical beauty industry and the role of technological innovation in driving industry upgrades [8]. - SILKROSE aims to contribute to a safer, more professional, and healthier development of the medical beauty industry, aligning with the "Healthy China" initiative [8].